Tormere Analytics
>/
OverviewMarket NewsStock ResearchChartsPortfolio LabOptions LabCalculatorsWatchlist
Data Explorer
Articles
Pricing
Privacy PolicyTerms of Service

Stephen J. Hill

Chief Operating Officer

SEC EDGAR ↗

Chief Operating Officer at Lyell Immunopharma, Inc., filing insider transactions between 2026-08-10 and 2026-08-21.

Total Purchases
—
0 transactions
Total Sales
$17K
2 transactions
Companies Traded
1
2 total filings
Active Since
2026-08-10
Last: 2026-08-21

Companies

LYEL2026-08-21

Lyell Immunopharma, Inc.

↓ $17K (2)

Other Reporting Insiders at Lyell Immunopharma, Inc.

  • ARCH Venture Fund XIII, L.P.
    10% Owner
    Last filing 2026-11-04
  • ARCH Venture Partners IX, LLC
    10% Owner
    Last filing 2026-11-04
  • Jarrad Mattieu Aguirre
    Chief Medical Officer
    Last filing 2026-10-12
  • David Shook
    Chief Medical Officer
    Last filing 2026-09-10
  • Lynn Seely
    Director & President and CEO
    Last filing 2026-08-21
  • Gary K. Lee
    Chief Scientific Officer
    Last filing 2026-08-21
  • Veronica Sanchez Bulis
    VP, Corporate Controller
    Last filing 2026-08-10

Transaction History

DateTickerTypeSharesPriceValueOwned After
2026-08-21LYELSale989$15.54$15K16.8KSEC ↗
2026-08-10LYELSale89$14.34$1K17.8KSEC ↗
Innovative Cellular Therapeutics Holdings Ltd
10% Owner
Last filing 2026-07-17